Work

Cost-effectiveness analysis of rezivertinib and gefitinib in patients with EGFR-mutated advanced non-small cell lung cancer

Year: 2026

Type: article

Source: Expert Review of Pharmacoeconomics & Outcomes Research

DOI: 10.1080/14737167.2026.2626573

Authors: Conghui Kou, Huina Wu, Lihui Liu, Xifeng Zhao, Jing Nie

Institution: Shandong Medical College

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Health Commission of Shandong Province

OpenAlex ID: W7127428125

FWCI:

Cites: 21

Cited by:

Related to: